The treatment induced higher numbers of CTLA-4negative anti-CD123 CAR T cells which exhibited superior cytotoxicity compared to CTLA-4positive anti-CD123 CAR T cells against AML target cells in vitro and in vivo. Here, IL3RA is linked to acute myeloid leukemia.